Similar articles for PMID: 21305387

Year	Number of Results
1989	1
2002	1
2003	1
2004	2
2005	4
2006	1
2007	5
2008	11
2010	8
2011	15
2012	24
2013	20
2014	17
2015	8
2016	11
2017	9
2018	5
2019	11
2020	9
2021	13
2022	8
2023	6
2024	0

1

Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate.

TrehanPati N, Kotillil S, Hissar SS, Shrivastava S, Khanam A, Sukriti S, Mishra SK, Sarin SK. TrehanPati N, et al. J Clin Immunol. 2011 Jun;31(3):509-20. doi: 10.1007/s10875-011-9509-7. Epub 2011 Feb 9. J Clin Immunol. 2011. PMID: 21305387

2

Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.

Sherman AC, Trehanpati N, Daucher M, Davey RT, Masur H, Sarin SK, Kottilil S, Kohli A. Sherman AC, et al. AIDS Res Hum Retroviruses. 2013 Apr;29(4):665-72. doi: 10.1089/AID.2012.0320. Epub 2013 Feb 11. AIDS Res Hum Retroviruses. 2013. PMID: 23259453 Free PMC article. Clinical Trial.

3

Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.

Li CZ, Hu JJ, Xue JY, Yin W, Liu YY, Fan WH, Xu H, Liang XS. Li CZ, et al. World J Gastroenterol. 2014 Jul 28;20(28):9486-96. doi: 10.3748/wjg.v20.i28.9486. World J Gastroenterol. 2014. PMID: 25071343 Free PMC article. Clinical Trial.

4

Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir.

Arasli M, Ustundag Y, Delikanli B, Harmandar F, Buyukuysal C. Arasli M, et al. Hepatogastroenterology. 2012 May;59(115):851-7. doi: 10.5754/hge11580. Hepatogastroenterology. 2012. PMID: 22193343

5

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.

Boni C, Janssen HLA, Rossi M, Yoon SK, Vecchi A, Barili V, Yoshida EM, Trinh H, Rodell TC, Laccabue D, Alfieri A, Brillo F, Fisicaro P, Acerbi G, Pedrazzi G, Andreone P, Cursaro C, Margotti M, Santoro R, Piazzolla V, Brunetto MR, Coco B, Cavallone D, Zhao Y, Joshi A, Woo J, Lau AH, Gaggar A, Subramanian GM, Massetto B, Fung S, Ahn SH, Ma X, Mangia A, Ferrari C. Boni C, et al. Gastroenterology. 2019 Jul;157(1):227-241.e7. doi: 10.1053/j.gastro.2019.03.044. Epub 2019 Mar 28. Gastroenterology. 2019. PMID: 30930022 Free article. Clinical Trial.

6

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F. Marcellin P, et al. N Engl J Med. 2008 Dec 4;359(23):2442-55. doi: 10.1056/NEJMoa0802878. N Engl J Med. 2008. PMID: 19052126 Free article. Clinical Trial.

7

Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.

Ma L, Cai YJ, Yu L, Feng JY, Wang J, Li C, Niu JQ, Jiang YF. Ma L, et al. Antimicrob Agents Chemother. 2013 Mar;57(3):1304-11. doi: 10.1128/AAC.02181-12. Epub 2012 Dec 28. Antimicrob Agents Chemother. 2013. PMID: 23274669 Free PMC article.

8

Recovery of circulating CD56^dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg.

Liu N, Liu B, Zhang L, Li H, Chen Z, Luo A, Chen M, Peng M, Yin W, Ren H, Hu P. Liu N, et al. Int Immunopharmacol. 2018 Sep;62:59-66. doi: 10.1016/j.intimp.2018.06.043. Epub 2018 Jul 5. Int Immunopharmacol. 2018. PMID: 29990695

9

Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial.

Lim YS, Gwak GY, Choi J, Lee YS, Byun KS, Kim YJ, Yoo BC, Kwon SY, Lee HC. Lim YS, et al. J Hepatol. 2019 Jul;71(1):35-44. doi: 10.1016/j.jhep.2019.02.021. Epub 2019 Mar 13. J Hepatol. 2019. PMID: 30876946 Clinical Trial.

10

Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals.

Chen LY, Zhu LY, Yang BS, Bi MR, Yan BZ, Wang W, Ma YJ. Chen LY, et al. Hepatogastroenterology. 2012 Nov-Dec;59(120):2582-6. doi: 10.5754/hge12287. Hepatogastroenterology. 2012. PMID: 22626879 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

161 results

Results by year